Pay in 4 interest-free payments of $5.11 Learn more
Ships within 48 hours Β· Estimated delivery Aug 20 - Aug 25
That means the exit strategy matters
GLP-1 as a trend has grown by 1054% in social discussion over the past year, according to Tastewise, a GenAI-powered consumer data platform (see graph below)
10%) over 20 weeks [100]
According to the Navadhi Global Peptide Therapy Market Strategic Research Report 2026-2031 Asia-Pacific is the fastest-growing region at 17.07% CAGR, driven by China's 140 million diabetics, Japan's post-PMDA approvals of Ozempic and Wegovy, and India emerging as the fastest-growing sub-market at 19.89% CAGR, leveraging GLP-1 biosimilar production
US$ 24.98
US$ 27.43
US$ 26.60
US$ 26.18
